G1 Cyclins and Control of the Cell Division Cycle in Normal and Transformed Cells

References

• Nurse P. Universal control mechanism regulating onset of M-phase. Nature 1990; 344: 503–508
   PubMed Web of Science ®Google Scholar
• Reed S I. The role of the p34 kinases in the G1 to S-phase transition. Annu Rev Cell Biol 1992; 8: 529–561
   PubMedGoogle Scholar
• Xiong Y, Connolly T, Futcher B, Beach D. Human D-type cyclin. Cell 1991; 65: 691–699
   PubMed Web of Science ®Google Scholar
• Lew D J, Dulic V, Reed S I. Isolation of three novel human cyclins by rescue of Gi cyclin (Cln) function in yeast. Cell 1991; 66: 1197–1206
   PubMed Web of Science ®Google Scholar
• Withers D A, Harvey R C, Faust J B, Melnyk O, Carey K, Meeker T C. Characterization of a candidate bcl-1 gene. Mol Cell Biol. 1991; 11: 4846–4853
   PubMed Web of Science ®Google Scholar
• Motokura T, Bloom T, Kim H G, Juppner H, Ruderman J V, Kronenberg H M, Arnold A. A novel cyclin encolded by a bell-linked candidate oncogene. Nature 1991; 350: 512–515
   PubMed Web of Science ®Google Scholar
• Motokura T, Bloom T, Kim H G, Juppner H, Ruderman J V, Kronenberg H M, Arnold A. A BCL-1 linked candidate oncogene which is rearranged in parathyroid tumors encodes a novel cyclin. Nature (Lond) 1991; 350: 512–518
   PubMed Web of Science ®Google Scholar
• Matsushime H, Roussel M F, Ashmun R A, Sherr C J. Colony-stimulating factor 1 regulates novel cyclins during the Gi phase of the cell cycle. Cell 1991; 65: 701–713
   PubMed Web of Science ®Google Scholar
• Xiong Y, Menninger J, Beach D, Ward D C. Molecular cloning and chromosomal mapping of CCND genes encoding human D-type cyclins. Genomics 1992; 13: 575–584
   PubMed Web of Science ®Google Scholar
• Motokura T, Keyomarsi K, Kronenberg H M, Arnold A. Cloning and characterization of human cyclin D3, a cDNA closely related in sequence to the PRADl/cyclin Dl proto-oncogene. J Biol Chem 1992; 267: 20412–20415
   PubMed Web of Science ®Google Scholar
• Aguzzi A, Kiess M, Riiedi D, Hamel P A. The different D-type cyclins are expressed in distinct tissues during mouse embryogene-sis. Transgenics 1996; 2: 29–39
   Google Scholar
• Ajchenbaum F, Ando K, DeCaprio J A, Griffin J D. Independent regulation of human D-type cyclin gene expression during Gi phase inprimary human T lymphocytes. J Biol Chem 1993; 268: 4113–4119
   PubMed Web of Science ®Google Scholar
• Kiyokawa H, Busquets X, Powell C T, Ngo L, Rifkind R A, Marks P A. Cloning of a D-type cyclin from murine erythroleukemia cells. Proc Natl Acad Sci USA 1992; 89: 2444–2447
   PubMed Web of Science ®Google Scholar
• Won K A, Xiong Y, Beach D, Gilman M Z. Growth-regulated expression of D-type cyclin genes in human diploid fibroblasts. Proc Natl Acad Sci USA 1992; 89: 9910–9914
   PubMed Web of Science ®Google Scholar
• Cocks B G, Vairo G, Bodrug S E, Hamilton J A. Suppression of growth factor-induced CYL1 cyclin gene expression by antiproliferative agents. J Biol Chem 1992; 267: 12307–12309
   PubMed Web of Science ®Google Scholar
• Kiess M, Gill R M, Hamel P A. Expression of the positive regulator of cell cycle progression, cyclin D3, is induced during differentiation of myoblasts into quiescent myotubes. Oncogene 1995; 10: 159–166
   PubMed Web of Science ®Google Scholar
• Loyer P, Glaise D, Cariou S, Baffet G, Meijer L, Guguen-Guillouzo C. Expression and activation of cdks (1 and 2) and cyclins in the cell cycle progression during liver regeneration. J Biol Chem 1994; 269: 2491–2500
   PubMed Web of Science ®Google Scholar
• Dulic V, Drullinger L F, Lees E, Reed S I, Stein G H. Altered regulation of Gi cyclins in senescent human diploid fibroblasts: Accumulation of inactive cyclin E-Cdk2 and cyclin-Cdk2 complexes. Proc Natl Acad Sci USA 1993; 90: 11034–11038
   PubMed Web of Science ®Google Scholar
• Daksis J I, Lu R Y, Facchini L M, Marhin W W, Penn L JZ. Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle. Oncogene 1994; 9: 3635–3645
   PubMed Web of Science ®Google Scholar
• Phillipp A, Schneider A, Vasrik I, Finke K, Xiong Y, Beach D, Alitalo K, Eilers M. Repression of cyclin Dl: A novel activity of MYC. Mol Cell Biol 1994; 14: 4032–4043
   PubMed Web of Science ®Google Scholar
• Bates S, Parry D, Bonetta L, Vousden K, Dickson C, Peters G. Absence of cyclin D/cdk complexes in cells lacking functional retionblastoma protein. Oncogene 1994; 9: 1633–1640
   PubMed Web of Science ®Google Scholar
• Miiller H, Lucas J, Schneider A, Warthoe P, Bartek J, Eilers M, Straus M. Cyclin Dl expression is regulated by the retinoblastoma protein. Proc Natl Acad Sci USA 1994; 91: 2945–2949
   PubMed Web of Science ®Google Scholar
• Lukas J, Bartkova J, Rohde M, Strauss M, Bartek J. Cyclin Dl is dispensable for Gi control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol Cell Biol 1995; 15: 2600–2611
   PubMed Web of Science ®Google Scholar
• Hamel P A, Gill R M, Phillips R A, Gallie B L. Transcriptional repression of the E2-containing promoters EIIaE, c-myc and RBI by the product of the RBI gene. Mol Cell Biol 1992; 12: 3431–3438
   PubMed Web of Science ®Google Scholar
• Hiebert S W, Chellappan S P, Horowitz J M, Nevins J R. The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev 1992; 6: 177–85
   PubMed Web of Science ®Google Scholar
• Hiebert S W, Lipp M, Nevins J R. ElA-dependent trans-activation of the human MYC promoter is mediated by the E2F factor. Proc Natl Acad Sci USA 1989; 86: 3594–3
   PubMed Web of Science ®Google Scholar
• Matsushime H, Ewen M E, Strom D K, Kato J Y, Hanks S K, Roussel M F, Sherr C J. Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type Gi cyclins. Cell 1992; 71: 323–334
   PubMed Web of Science ®Google Scholar
• Rosenwald I B, Lazaris-Karatzas A, Sonenberg N, Schmidt E V. Elevated levels of cyclin Dl protein in response to increased expression of eukaryotic initiation factor 4E. Mol Cell Biol 1993; 13: 7358–7363
   PubMed Web of Science ®Google Scholar
• Labbe J C, Picard A, Peaucellier G, Cavadore J C, Nurse P, Doree M. Purification of MPF from starfish: Identification as the HI histone kinase p34cdc2 and a possible mechanism for its periodic activation. Cell 1989; 57: 253–263
   PubMed Web of Science ®Google Scholar
• Norbury C J, Nurse P. Control of the higher eukaryote cell cycle by p34c<fc2 homologues. Biochem Biophys Acta 1989; 989: 85–95
   PubMed Web of Science ®Google Scholar
• Tsai L-H, Harlow E, Meyerson M. Isolation of the human cdk2 gene that encodes the cyclin A- and adenovirus El A-associated p33 kinase. Nature 1991; 353: 174–177
   PubMed Web of Science ®Google Scholar
• Xiong Y, Zhang H, Beach D. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 1992; 71: 505–514
   PubMed Web of Science ®Google Scholar
• Meyerson M, Harlow E. Identification of Gl kinase activity for cdk6, a novel cyclin D partner. Mol Cell Biol 1994; 14: 2077–2086
   PubMed Web of Science ®Google Scholar
• Lew J, Huang Q-Q, Qi Z, Winkfein R J, Aebersold R, Hunt T, Wang J H. A brain-specific activator of cyclin-dependent kinase 5. Nature 1994; 371: 423–426
   PubMed Web of Science ®Google Scholar
• Tsai L-H, Delalle I, Caviness V S, Chae T, Harlow E. p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 1994; 371: 419–423
   PubMed Web of Science ®Google Scholar
• Solomon M J, Harper J W, Shuttleworth J. CAK, the p34edc2 activating kinase contains a protein identical to or closely related to p40M015. EMBO J 1993; 12: 3133–3142
   PubMed Web of Science ®Google Scholar
• Poon R YC, Yamashita K, Adamczewski J P, Hunt T, Shuttleworth J. The cdc2-related protein p40M015 is the catalytic subunit of a protein kinase that can activate p33cdk2 and p34cdc2. EMBO J 1993; 12: 3123–3132
   PubMed Web of Science ®Google Scholar
• Fesquet D, LabbS J-C, Galas S, Girard F, Lorca T, Shuttleworth J, Doree M, Cavadore J-C. The M015 gene encodes the catalytic subunit of a protein kinase that activates cdc2 and other cyclin-dependent kinases (CDKs) through phosphorylation of Thrl61 and its homologues. EMBO J 1993; 12: 3111–3121
   PubMed Web of Science ®Google Scholar
• Wu L, Yee A, Liu L, Carbonaro-Hall D, Venkatesan N, Tolo V T, Hall F L. Molecular cloning of the human CAK1 gene encoding a cyclin-dependent kinase-activating kinase. Oncogene 1994; 9: 2089–2096
   PubMed Web of Science ®Google Scholar
• van den Heuvel S, Harlow E. Distinct roles for cyclin-dependent kinases in cell cycle control. Science 1993; 262: 2050–2054
   PubMed Web of Science ®Google Scholar
• Xiong Y, Hannon G J, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 1993; 366: 701–704
   PubMed Web of Science ®Google Scholar
• Harper J W, Adami G R, Wei N, Keyomarsi K, Elledge S J. The p21 Cdk-interacting protein Cipl is a potent inhibitor of Gl cyclin-dependent kinases. Cell 1993; 75: 805–816
   PubMed Web of Science ®Google Scholar
• El-Deiry W S, Tokino T, Velculescu V E, Levy D B, Parsons R, Trent J M, Lin D, Mercer W E, Kinzler K W, Vogelstein B. WAF1 a potential mediator of p53 tumor suppression. Cell 1993; 75: 817–825
   PubMed Web of Science ®Google Scholar
• Zhang H, Hannon G J, Beach D. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev 1994; 8: 1750–1758
   PubMed Web of Science ®Google Scholar
• Waga S, Hannon G J, Beach D, Stillman B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 1994; 369: 574–578
   PubMed Web of Science ®Google Scholar
• Polyak K, Kato J, Solomon M J, Sherr C J, Massague J, Roberts J M, Koff A. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor p and contact inhibition to cell cycle arrest. Genes Dev 1994; 8: 9–22
   PubMed Web of Science ®Google Scholar
• Polyak K, Lee M-H, Erdjument-Bromage H, Koff A, Roberts J M, Tempst P, Massague J. Cloning of ?pT1K′pl a cyclin-dependent kinase inhibitor and potential mediator of extracellular antimito-genic signals. Cell 1994; 78: 59–66
   PubMed Web of Science ®Google Scholar
• Toyoshima H, Hunter T. p27, a novel inhibitor of Gl cyclin-cdk protein kinase activity, is related to p21. Cell 1994; 78: 67–74
   PubMed Web of Science ®Google Scholar
• Hengst L, Dulic V, Slingerland J M, Lees E, Reed S I. A cell cycle regulated inhibitor of cyclin dependent kinases. Proc Natl Acad Sci USA 1994; 91: 5291–5295
   PubMed Web of Science ®Google Scholar
• Matsuoka S, Edwards M C, Bai C, Parker S, Zhang P, Baldini A, Harper J W, Elledge S J. p57, a structurally distinct member of the p21 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev 1995; 9: 650–662
   PubMed Web of Science ®Google Scholar
• Lee M-H, Reynisdotfir I, Massague J. Cloning of p57,acyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 1995; 9: 639–649
   PubMed Web of Science ®Google Scholar
• Serrano M, Hannon G, Beach D. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993; 366: 704–707
   PubMed Web of Science ®Google Scholar
• Hannon G J, Beach D. pl5 is a potential effector of cell cycle arrest mediated by TGFp\. Nature 1994; 371: 257–261
   PubMed Web of Science ®Google Scholar
• Guan K-L, Jenkins C W, Li Y, Nichols M A, Wu X, O'Keefe C L, Matera A G, Xiong Y. Growth suppression by pi 8, a p 16′ -related cdk6 inhibitor, correlates with wild type pRb function. Genes Dev 1994; 8: 2939–2952
   PubMed Web of Science ®Google Scholar
• Hirai H, Rouseel M F, Kato J-Y, Ashmun R A, Sherr C J. Novel INK4 proteins, pl9 and pl8, are specific inhibitors of the cyclein D-dependent kinases, cdk4 and cdk6. Mol Cell Biol 1995; 15: 2672–2681
   PubMed Web of Science ®Google Scholar
• Chan F KM, Zhang J, Cheng L, Shapiro D N, Winoto A. Identification of human and mouse pl9, a novel CDK4 and CDK6 inhibitor with homology top161nk4. Mol Cell Biol 1995; 15: 2682–2688
   PubMed Web of Science ®Google Scholar
• Sherr C J, Roberts J M. Inhibitors of mammalian Gi cyclin-dependent kinases. Genes Dev 1995; 9: 1149–1163
   PubMed Web of Science ®Google Scholar
• Gyuris J, Golemis E, Chertkov H, Brent R. Cdil, a human GI and S phase protein phosphatase that associates withcdk2. Cell 1993; 75: 791–803
   PubMed Web of Science ®Google Scholar
• Hannon G J, Casso D, Beach D. KAP: A dual specificity phosphatase that interacts with cyclin-dependent kinases. Proc Natl Acad Sci USA 1994; 91: 1731–1735
   PubMed Web of Science ®Google Scholar
• Resnitzky D, Gossen M, Bujard H, Reed S I. Acceleration of the Gi/S phase transition by expression of cyclins Dl and E with an inducible system. Mol Cell Biol 1994; 14: 1669–1679
   PubMed Web of Science ®Google Scholar
• Wimmel A, Lucibello F C, Sewing A, Adolph S, Muller R. Inducible acceleration of G1 progression through tetracycline-regulated expression of human cyclin E. Oncogene 1994; 9: 995–997
   PubMed Web of Science ®Google Scholar
• Jiang W, Kahn S M, Zhou P, Zhang Y-J, Cacace A M, Infante A S, Doi S, Santella R M, Weinstein I B. Overexpression of cyclin Dl in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene 1993; 8: 3447–3457
   PubMed Web of Science ®Google Scholar
• Kato J-Y, Sherr C J. Inhibition of granulocyte differentiation by Gi cyclins D2 and D3 but not Dl. Proc Natl Acad Sci USA 1993; 90: 11513–11517
   PubMed Web of Science ®Google Scholar
• Baldin V, Lukas J, Marcote M J, Pagano M, Draetta G. Cyclin Dl is a nuclear protein required for cell cycle progression in Gi. Genes Dev 1993; 7: 812–821
   PubMed Web of Science ®Google Scholar
• Koff A, Ohtsuki M, Polyak K, Roberts J, Massague J. Negative regulation of GI in mammalian cells: Inhibition of cyclin E-de-pendent kinase by TGF-b. Science 1993; 260: 536–539
   PubMed Web of Science ®Google Scholar
• Ewen M E, Sluss H K, Whitehouse L L, Livingston D M. TGBβ inhibition of cdk4 synthesis is linked to cell cycle arrest. Cell 1993; 74: 1009–1020
   PubMed Web of Science ®Google Scholar
• Ewen M E, Oliver C J, Sluss H K, Miller S J, Peeper D S. p53-depend-enl repression of cdk4 translation in TGF-B-induced Gi cell-cycle arrest. Genes Dev 1995; 9: 204–207
   PubMed Web of Science ®Google Scholar
• Hinds P W, Mittnacht S, Dulic V, Arnold A, Reed S I, Weinberg R A. Regulation of retinoblastoma functions by ectopic expression of human cyclins. Cell 1992; 70: 993–1006
   PubMed Web of Science ®Google Scholar
• Kato J, Matsushime H, Hiebert S W, Ewen M E, Sherr C J. Direct binding of cyclin D to the retinoblastoma gene product (pRB) and pRB phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev 1993; 7: 331–342
   PubMed Web of Science ®Google Scholar
• Ewen M E, Sluss H K, Sherr C J, Matsushime H, Kato J, Livingston D M. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 1993; 73: 487–497
   PubMed Web of Science ®Google Scholar
• Wang C, Petryniak B, Thompson C B, Kaelin W G, Leiden J M. Regulation of the Ets-related transcription factor Elf-1 by binding the retinoblastoma protein. Science 1993; 260: 1330–1335
   PubMed Web of Science ®Google Scholar
• Devoto S H, Mudryj M, Pines J, Hunter T, Nevins J R. A cyclin A-protein kinase complex possesses sequence-specific DNA binding activity: p33cdk2 is a component of the E2F-cyclin A complex. Cell 1992; 68: 167–176
   PubMed Web of Science ®Google Scholar
• Krek W, Ewen M E, Shirodkar S, Arany Z, Kaelin W G, Jr, Livingston D M. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell 1994; 78: 161–172
   PubMed Web of Science ®Google Scholar
• Hannon G J, Demetrick D, Beach D. Isolation of the Rb-related pl30 through its interaction with cdk2 and cyclins. Genes Dev 1993; 7: 2378–2391
   PubMed Web of Science ®Google Scholar
• Li Y, Graham C, Lacy S, Duncan A MV, Whyte P. The adenovirus Ela-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Dev 1993; 7: 2366–2377
   PubMed Web of Science ®Google Scholar
• Ewen M E, Xing Y G, Lawrence J B, Livingston D M. Molecular cloning, chromosomal mapping, and expression of the cDNA for p 107, aretinoblastoma gene product-related protein. Cell 1991; 66: 1155–1164
   PubMed Web of Science ®Google Scholar
• Dowdy S F, Hinds P W, Louie K, Reed S I, Arnold A, Weinberg R A. Physical interaction of the retinoblastoma protein with human D cyclins. Cell 1993; 73: 499–511
   PubMed Web of Science ®Google Scholar
• Dyson N, Howley P M, Miinger K, Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989; 242: 934–937
   Google Scholar
• Whyte P, Buchkovich K J, Horowitz J M, Friend S H, Raybuck M, Weinberg R A, Harlow E. Association between an oncogene and an anti-oncogene: The adenovirus El A proteins binds to the retinoblastoma gene product. Nature 1988; 334: 124–129
   PubMed Web of Science ®Google Scholar
• DeCaprio J A, Ludlow J W, Figge J, Shew J Y, Huang C M, Lee W H, Marsilio E, Paucha E, Livingston D M. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 1988; 54: 275–83
   PubMed Web of Science ®Google Scholar
• Lees E, Faha B, Dulic V, Reed S I, Harlow E. Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with pl07 and E2F in a temporally distinct maimer. Genes Dev 1992; 6: 1874–1885
   PubMed Web of Science ®Google Scholar
• Ewen M E, Faha B, Harlow E, Livingston D M. Interaction of p 107 with cyclin A independent of complex formation with viral oncopo-teins. Science 1992; 255: 85–87
   PubMed Web of Science ®Google Scholar
• Faha B, Ewen M E, Tsai L-H, Livingston D M, Harlow E. Interaction between human cyclin A and adenovirus E1 A-associated p 107 protein. Science 1992; 255: 87–90
   PubMed Web of Science ®Google Scholar
• Hunter T, Pines J. Cyclins and cancer I. I. Cyclin D and CDK inhibitors come of age. Cell 1994; 4: 573–582
   Google Scholar
• Rosenberg C L, Wong E, Petty E M, Bale A E, Tsujimoto Y, Harris N L, Arnold A. PRAD1 a candidate BCL-1 oncogene: Mapping and expression in centrocylic lymphoma. Proc Natl Acad Sci USA 1991; 87: 9638–9642
   Google Scholar
• Selo M, Yamamoto K, Iida S, Akao Y, Utsumi K R, Kuonishi I, Miyoshi I, Ohtsuki T, Yawala Y, Namba M, Motokura T, Arnold A, Takahashi T, Ueba R. Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(l 1;14)(q13;q32) translocation. Oncogene 1992; 7: 1401–1406
   PubMed Web of Science ®Google Scholar
• Bodrug S, Warner B, Bath M, Lindeman G, Harris A, Adams J. Cyclin D1 transgene impedes lymphocyte maturation and collaborates with the myc gene. EMBO J 1994; 13: 2124–2130
   PubMed Web of Science ®Google Scholar
• Hinds P W, Dowdy S F, Eaton E N, Arnold A, Weinberg R A. Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci USA 1994; 91: 709–713
   PubMed Web of Science ®Google Scholar
• Jung J U, Stager M, Desrosiers R C. Virus-encoded cyclin. Mol Cell Biol 1994; 14: 7235–7244
   PubMed Web of Science ®Google Scholar
• Inaba T, Matsushime H, Valentine M, Roussel M F, Sherr C J, Look A T. Genomic organization, chromosomal localization, and independent expression of human cyclin D genes. Genomics 1992; 13: 565–574
   PubMed Web of Science ®Google Scholar
• Leach F S, Elledge S J, Sherr C J, Wilson J K, Markowitz S, Kinzer K W, Vogelstein B. Amplification of cyclin genes in colorectal carcinomas. Cancer Res 1993; 53: 1986–1989
   PubMed Web of Science ®Google Scholar
• Hanna Z, Jankowski M, Tremblay P, Jiang X, Milatovitch A, Francke U, Jolicoeur P. The vin-1 gene, identified by provirus insertional mutatgenesis, is the cyclinD2. Oncogene 1993; 8: 1661–1666
   PubMed Web of Science ®Google Scholar
• Keyomarsi K, O'Leary N, Molnar G, Lees E, Fingert H J, Pardee A B. Cyclin E, a potential prognostic marker for breast cancer. Cancer Res 1994; 54: 380–385
   PubMed Web of Science ®Google Scholar
• Keyomarsi K, Pardee A B. Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci USA 1993; 90: 1112–1116
   PubMed Web of Science ®Google Scholar
• Buckley M F, Sweeny K J, Hamilton J A, Sini R L, Manning D L, Nicholson R I, de Fazio A, Watts C K, Musgrove E A, Sutherland R L. Expression and amplification of cyclin genes in human breast cancer. Oncogene 1993; 8: 2127–2133
   PubMed Web of Science ®Google Scholar
• Quelle D E, Ashmun R A, Shurtleff S A, Kato J-Y, Bar-Sagi D, Roussel M F, Sherr C J. Overexpression of mouse D-type cyclins accelerates G1-phase progression in rodent fibroblasts. Genes Dev 1993; 7: 1559–1571
   PubMed Web of Science ®Google Scholar